Activity ID
13306Expires
June 23, 2027Format Type
EnduringCME Credit
1Fee
150CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)
Description of CME Course
In the US, drug and opioid overdose deaths have nearly quadrupled over the last decade. Synthetic opioid-related deaths increased 850% in women. Nearly 85% of pregnancies in women with substance use disorder (SUD) are unintended. During pregnancy, chronic untreated substance and opioid use disorders are associated with lack of prenatal care, preterm birth, fetal death, and other pregnancy complications. Fetal effects of substance use disorder are many: drug metabolite exposure, teratogenic effects, abnormal growth, decreased fetal movements, and NAS. This activity will present an overview of SUD in pregnancy and highlight strategies to assist with addressing the issues.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Family Medicine
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
a. Recognize substance and opioid use disorders as treatable, chronic diseases.
b. Utilize diagnostic criteria to identify pregnant patients with SUD.
Keywords
Substance abuse, substance use disorder, SUD, opioid use
Competencies
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement, Professionalism
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Outpatient, Rural, Urban, VA/Military
